I am an anaesthestist for 40 years and 99 % of surgeons will do everything for their patients outcome despite their personal personalities. A total knee replacement costs $30,000 so the heart surgeon will spend $2000 for an adapt artery product to get a good outcome for his or her patient if the patients donor leg vein graft is unsuitable for coronary grafting. If in doubt do you use it or go for Admedus adapt VC ?
We are heading for a brand market so lets go for a premium price in due course.
"Take a Closer Look", page-651
-
- There are more pages in this discussion • 577 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $294.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 276 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |